November news round-up

Linear Diagnostics staff pose for photo with Midven representatives
Cell therapy image

CAR-T success for UHB patient

A patient at the Queen Elizabeth Hospital Birmingham (QEHB) has become the first in the Midlands to have a successful CAR-T cell therapy, for treatment of her cancer. Sophie Wheldon, aged 21, was diagnosed with leukaemia in June 2018. She went on to receive an unrelated donor stem cell transplant in November but the disease … Continue reading

unhappy young girl

Unique partnership to improve Birmingham’s youth mental health

A unique city partnership to improve the mental health and future potential of children living in Birmingham has been announced during Anti-Bullying Week 2019 (Monday 11 to Friday 15 November). Three of the region’s most prestigious organisations, BHP founder members University of Birmingham and Birmingham Children’s Hospital plus HSBC UK have joined forces to take … Continue reading

Selfridges building and blue skies

Improving air quality and health – for all

Poor air quality is one of the major public health challenges in Birmingham. We know that the negative impacts of poor air quality are worse for the poorest, most vulnerable residents and those with long-term health conditions. 

And so, on Wednesday 20th November, well over 100 people gathered at the Queen Elizabeth Hospital – all showing a real commitment … Continue reading

MD-TEC facility - simulation dummy

Medtech worth £1.6bn to Midlands economy

Medtech is of critical importance to the Midlands economy, a new report has found.  The report focuses upon the nature and scale of the medtech sector, its contribution to the regional economy, what Midlands businesses need in order to achieve growth, and the barriers faced. Key findings from the Midlands MedTech Sector Analysis include the … Continue reading

Linear Diagnostics staff pose for photo with Midven representatives

Spin-out secures major investment for diagnostic technology

Linear Diagnostics Limited (LDL), a spin-out from BHP founder member the University of Birmingham, has secured £2m of investment from MEIF and other investors to develop new platform technology for medical diagnostic testing. Following extensive research, LDL is to create a platform that is able to provide multiple diagnoses in a Point of Care environment. … Continue reading

inflammation and the knee joint

Researchers find potential new target for treatment of inflammatory disease

Researchers led by BHP founder member the University of Birmingham have found a potential new target to treat inflammatory disease. The research, led by scientists at the University of Birmingham’s Institute of Inflammation and Ageing, Institute of Cardiovascular Sciences, and Institute of Metabolism and Systems Research, publishes today (November 7th) in Cell Metabolism. The team … Continue reading